Learn about the role of HPV in cervical cancer
What's New

24. April 2014

FDA Approves Roche's HPV Test for First-Line Primary Screening for Cervical Cancer 

Expanded indication makes cobas® HPV Test the only test approved in U.S. that can be used instead of Pap in first-line primary screening in women 25 and older.


07. April 2014

Roche acquires IQuum to strengthen offerings in molecular diagnostics

IQuum’s unique products will allow Roche to quickly enter the point of care segment of molecular diagnostics


19. March 2014

Roche launches the cobas® Cdiff Test for detection of Clostridium difficile in markets accepting the CE mark 

New test expands menu for hospital-acquired infections testing on the cobas® 4800 System.


 Diagnostic and Blood Screening Tests


Roche Molecular Diagnostics (RMD) offers a uniquely broad range of diagnostic and blood screening assays based on the company's Nobel prize-winning PCR technologies.


RMD's tests and automated platforms are focused in the areas of virology, blood screening, HPV, genomics and oncology, microbiology and sexually transmitted infections. > more


Contact your local sales representative for detailed information, questions and ordering.



 Browse Our Products

 Related Links